CCI
NVAX icon

Columbus Circle Investors’s Novavax NVAX Stock Holding History

Columbus Circle Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,012
Closed -$1.63M – 173
2020
Q3 		$1.63M Buy
+15,012
New +$1.83M 0.07% 141

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Columbus Circle Investors's NVAX Position: Q4 2020 in Review

Columbus Circle Investors sold out of Novavax (NVAX) in Q4 2020, closing a stake of 15,012 shares — an estimated $1.63M sold.

Columbus Circle Investors first reported a position in NVAX in Q3 2020 and held it in 1 quarter. The position peaked at $1.63M in Q3 2020. 347 funds tracked by Wall St. Rank hold NVAX as of Q4 2020.

  • Columbus Circle Investors reported no remaining Novavax position as of Q4 2020 after selling out during the quarter.
  • Columbus Circle Investors sold 15,012 Novavax shares in Q4 2020, an estimated $1.63M.
  • Columbus Circle Investors first reported a position in Novavax in Q3 2020 and held it in 1 quarter.
  • Columbus Circle Investors's Novavax position peaked at $1.63M in Q3 2020.
  • 347 funds tracked by Wall St. Rank held Novavax as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.